Two new HIV drugs, Emtriva and Reyataz
August 2003
Two new HIV drugs, Emtriva and Reyataz, will help simplify drug regimens...because they're each given just ONCE a day.
Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir).
Emtriva is well-tolerated. It DOESN'T affect cytochrome P450 enzymes...therefore drug interactions aren't likely.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote